These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 6780254

  • 21. Physical and kinetic properties of beta-glucosidase in Gaucher disease.
    Karazeh A, Carroll M.
    J Inherit Metab Dis; 1983; 6(3):101-4. PubMed ID: 6422137
    [Abstract] [Full Text] [Related]

  • 22. A revised fluorometric assay for Gaucher's disease using conduritol-beta-epoxide with liver as the source of Beta-glucosidase.
    Daniels LB, Glew RH, Radin NS, Vunnam RR.
    Clin Chim Acta; 1980 Sep 25; 106(2):155-63. PubMed ID: 6773704
    [Abstract] [Full Text] [Related]

  • 23. The change in the pH 4 and pH 6 forms of alpha-glucosidase in cultured amniotic fluid cells and its implication in prenatal diagnosis of Pompe's disease.
    Fujimoto A, Fluharty AL.
    Clin Chim Acta; 1978 Dec 01; 90(2):157-61. PubMed ID: 31251
    [Abstract] [Full Text] [Related]

  • 24. Utility of amniotic fluid chitotriosidase in the prenatal diagnosis of lysosomal storage disorders.
    Kadali S, Madalasa T, Reddy GM, Naushad SM.
    Clin Biochem; 2018 Nov 01; 61():40-44. PubMed ID: 30205089
    [Abstract] [Full Text] [Related]

  • 25. Comparison of various beta-glucosidase assays used to diagnose Gaucher's disease.
    Chiao YB, Glew RH, Diven WF, Lee RE.
    Clin Chim Acta; 1980 Jul 17; 105(1):41-50. PubMed ID: 6772352
    [No Abstract] [Full Text] [Related]

  • 26. Genetic heterogeneity in Gaucher disease: physicokinetic and immunologic studies of the residual enzyme in cultured fibroblasts from non-neuronopathic and neuronopathic patients.
    Grabowski GA, Goldblatt J, Dinur T, Kruse J, Svennerholm L, Gatt S, Desnick RJ.
    Am J Med Genet; 1985 Jul 17; 21(3):529-49. PubMed ID: 3927728
    [Abstract] [Full Text] [Related]

  • 27. Multiple forms of membrane-bound beta-glucosidase in Gaucher's disease.
    Yaqoob M, Carroll M.
    Clin Genet; 1981 Aug 17; 20(2):161-7. PubMed ID: 6796311
    [Abstract] [Full Text] [Related]

  • 28. Prenatal diagnosis of type II glycogenosis (Pompe's disease) using microchemical analyses.
    Niermeijer MF, Koster JF, Jahodova M, Fernandes J, Heukels-Dully MJ, Galjaard H.
    Pediatr Res; 1975 May 17; 9(5):498-503. PubMed ID: 1055986
    [Abstract] [Full Text] [Related]

  • 29. Evidence for the deficiency of beta-glucosidase-activating factor in fibroblasts of patients with I-cell disease.
    Varon R, Kleijer WJ, Thompson EJ, d'Azzo A.
    Hum Genet; 1982 May 17; 62(1):66-9. PubMed ID: 6818133
    [Abstract] [Full Text] [Related]

  • 30. Qualitative characteristics of the beta-glucosidase isozymes.
    Choy FY, Davidson RG.
    Prog Clin Biol Res; 1982 May 17; 95():415-41. PubMed ID: 6812079
    [No Abstract] [Full Text] [Related]

  • 31. Effectors of three beta-glucosidases from human liver.
    Daniels LB, Gnarra JR, Glew RH.
    Prog Clin Biol Res; 1982 May 17; 95():333-55. PubMed ID: 6812077
    [Abstract] [Full Text] [Related]

  • 32. Diagnosis of Gaucher's disease in cultured skin fibroblasts and leucocytes.
    Butterworth J, Broadhead DM.
    J Inherit Metab Dis; 1978 May 17; 1(3):111-3. PubMed ID: 116079
    [Abstract] [Full Text] [Related]

  • 33. In vitro detergent activation of lysosomal acid beta-glucosidase in the spleen of normal and type 1 Gaucher patients is not accompanied by change in aggregation state.
    Maret A, Potier M, Salvayre R, Troly M, Beauregard G, Douste-Blazy L.
    Biochim Biophys Acta; 1989 Jul 06; 996(3):254-6. PubMed ID: 2502183
    [Abstract] [Full Text] [Related]

  • 34. Leukocyte beta-glucosidase in homozygotes and heterozygotes for Gaucher disease.
    Raghavan SS, Topol J, Kolodny EH.
    Am J Hum Genet; 1980 Mar 06; 32(2):158-73. PubMed ID: 6770675
    [Abstract] [Full Text] [Related]

  • 35. Studies on human acid beta-glucosidase and the nature of the molecular defect in type 1 Ashkenazi Gaucher disease.
    Gatt S, Dinur T, Desnick RJ.
    Prog Clin Biol Res; 1982 Mar 06; 95():315-31. PubMed ID: 6812076
    [No Abstract] [Full Text] [Related]

  • 36. Human acid beta-glucosidase. Use of conduritol B epoxide derivatives to investigate the catalytically active normal and Gaucher disease enzymes.
    Grabowski GA, Osiecki-Newman K, Dinur T, Fabbro D, Legler G, Gatt S, Desnick RJ.
    J Biol Chem; 1986 Jun 25; 261(18):8263-9. PubMed ID: 3087971
    [Abstract] [Full Text] [Related]

  • 37. Gaucher disease (type 1): physical and kinetic properties of liposomal and soluble 'acid' beta-glucosidase.
    Carroll M.
    J Inherit Metab Dis; 1985 Jun 25; 8(1):33-7. PubMed ID: 3921758
    [Abstract] [Full Text] [Related]

  • 38. Enzyme analysis of amniotic fluid for prenatal diagnosis of cystic fibrosis in high-risk pregnancies.
    Peretz H, Chemke J, Usher S, Legum C, Graff E.
    Clin Chem; 1988 Dec 25; 34(12):2401-5. PubMed ID: 2904307
    [Abstract] [Full Text] [Related]

  • 39. Sodium taurocholate effect on beta-glucosidase activity: a new approach for identification of Gaucher disease using the synthetic substrate and leucocytes.
    Magalhães J, Sá Miranda MC, Pinto R, Lemos M, Poenaru L.
    Clin Chim Acta; 1984 Aug 31; 141(2-3):111-8. PubMed ID: 6435915
    [Abstract] [Full Text] [Related]

  • 40. Modification of subunit interaction in membrane-bound acid beta-glucosidase from Gaucher disease.
    Maret A, Potier M, Salvayre R, Douste-Blazy L.
    FEBS Lett; 1983 Aug 22; 160(1-2):93-7. PubMed ID: 6411492
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.